VANCOUVER, British Columbia--(BUSINESS WIRE)--Feb. 25, 2000--
Lasik Vision(CDNX:LSK)
Company Continues to Experience Record Procedural
Bookings into 2000
Lasik Vision Corporation ("Lasik Vision") (CDNX:LSK) announced
today that consumer response to its high-quality, affordable care
model continues to experience high consumer acceptance. The recent
announcement by VISX (NASDAQ:VISX) to aggressively reduce its excimer
laser licensing fee will make a significant contribution to Lasik
Vision profitability this year as the cost base of the company's
existing forecasts were based on the former fee.
Lasik Vision, the pioneer of affordable, high-quality laser
vision correction, continues to experience rapid growth in procedural
volume spurred by the high word-of-mouth referral of satisfied
patients. "We are very encouraged by the response of the public to our
high standards of care and our focus on affordability," said Michael
Henderson, President and CEO of Lasik Vision Corporation. "This fee
reduction is very exciting for us, as we believe that cost is the most
significant factor keeping people from having this procedure. This new
lower fee gives us more flexibility in our pricing structure and
allows us to ensure we will be able to offer the best price to our
patients. It will also enhance the company's ability to capture a
larger portion the growing market for LASIK."
Based in Vancouver, B.C., Lasik Vision Corporation is Canada's
largest operating laser vision correction company. Lasik Vision has
already performed more than 68,000 procedures in Canada at its 15
centers. Through its U.S. subsidiary, Lasik Vision U.S.A., Lasik
Vision Corporation operates a clinic in Bellevue, Washington. Lasik
Vision centers offer vision correction procedures, including PRK
(Photo Refractive Keratectomy) and LASIK (Laser Assisted in- Situ
Keratomileusis), to correct near- and far-sightedness and astigmatism
with advanced excimer lasers and state-of-the-art topography and
microkeratome equipment.
With many of the most experienced specialists in North America,
Lasik Vision's goal is to provide the best quality patient care and
clinical outcomes at the most affordable price for patients.
Additional information on the company may be obtained at
www.lasik-vision.com.
Statements and/or financial forecasts that are not historical are
to be regarded as forward-looking statements, which are subject to
risks and uncertainties and could cause actual results to differ
materially. Such risks and uncertainties with respect to Lasik
Vision's business include but are not limited to: (i) general economic
conditions, (ii) limited operating history, (iii) continued industry
and public acceptance, (iv) regulatory compliance, (v) potential
liability or malpractice claims, (vi) future capital requirements and
uncertainty of additional funding and (vii) dependence on key
personnel. These forward- looking statements should not be reprinted,
reiterated nor considered an inducement for investment.
On behalf of the Board of Directors of
LASIK VISION CORPORATION
Michael R. Henderson, President and CEO
The Canadian Venture Exchange nor any other exchange or other
regulatory body has reviewed and therefore does not accept
responsibility for the adequacy or accuracy of this release.
--30--jlm/in*
CONTACT: Lasik Vision Corporation
Michael Henderson, 877/801-4888
Website: www.lasik-vision.com
KEYWORD: INTERNATIONAL CANADA
INDUSTRY KEYWORD: PHARMACEUTICAL |
